ST Wanbang announced that Wanbang Pharmaceutical, a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for sulpiride tablets approved and issued by the State Drug Administration. The specification is 0.1 g, and the registration classification is 3 types of chemicals. The drug has obtained this certificate as if it has passed the consistent evaluation of the quality and efficacy of generic drugs. It is a category in the medical insurance and basic drug catalogue, and is used to treat schizophrenia, etc. This approval has enriched the company's anti-mental illness drug product line and strengthened the advantages of the integrated API + formulation model. However, drug production and sales are affected by policies and markets, and there is uncertainty.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.